Secondary
Eloxx Pharmaceuticals, Inc.
We are a global biopharmaceutical company focused on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases.
Symbol
ELOX
Last Closing Price
$9.75
Anticipated Date
TBD
Underwriters
Citigroup, Piper Jaffray, Canaccord Genuity, SunTrust Robinson Humphrey
To view the prospectus for Eloxx Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277